Mahmoud A. Eltorky, M.D., Ph.D.
Professor and Director of Surgical Pathology, Department of Pathology
Pulmonary, Breast and Cytopathology, Consultant
AP-CP and Cytopathology Board Certified
University of Texas Medical Branch
2.180 John Sealy Annex
301 University Boulevard
Galveston, TX 77555-0588
Office: (409) 772-0614
|Degree||Institution||Field of Study||Graduation Year|
|M.D.||College of Medicine, Alexandria University, Alexandria, Egypt, with honors||Biological Sciences||1971|
|Ph.D.||The University of Tennessee, Memphis, TN||Pathology||1983|
|Residency||University of Tennessee & Baptist Memorial Hospital, Department of Pathology, Memphis, TN,||Anatomic & Clinical Pathology||1987|
|Fellowship||University of Tennessee & Baptist Memorial Hospital, Department of Pathology, Memphis, TN||1988|
|Department of Pathology, University of North Carolina, Chapel Hill, NC||1989|
|Department of Pulmonary & Mediastinal Pathology, Armed Forces Institute of Pathology,
|University of Pittsburgh, Department of Pathology, Pittsburgh, PA||1991|
|2002-Present||Tenure, Professor of Pathology and Director of Surgical Pathology, University of Texas Medical Branch, Galveston, TX|
|1999-2002||Tenure Professor of Pathology, University of Tennessee, Memphis, TN|
|1996-1999||Tenure, Associate Professor, University of Tennessee, Memphis, TN|
|1994-2002||Director of Surgical Pathology and Cytopathology Divisions, pulmonary pathology consultant, University of Tennessee, Memphis, TN|
|1993-1996||Associate Professor of Pathology, Pulmonary Pathology Consultant University of Tennessee, Memphis, TN|
|1990-1993||Assistant Professor of Pathology, University of Tennessee, Memphis, TN|
|1988-1990||Instructor of Pathology, University of Tennessee, Memphis, TN|
Lung cancer is the leading cause of cancer death in men and women accounting for 157,200 deaths in 2003 and corresponding to 28% of all cancer deaths. Specifically lung cancer causes 88,400 (31%) deaths in men and 68,800 (25%) deaths in women.
Death rates for lung cancer have been rising from 40 per 100,000 in the male population in 1962 to 81 per 100,000 in 2003 and among women from 7 per 100,000 to 51.4 per 100,000 during the same period of time. In women, lung cancer has become the major cause of death followed by breast cancer which for the previous 40 years has been the major cause of cancer death in women. All histologic types of lung cancer have contributed to the increase of incidence of lung cancer, but the distribution of each type has varied over the past years. Our local experience and published data showed that in men the most common type of lung cancer is still squamous cell carcinoma, followed by adenocarcinoma and small cell carcinoma. In women the most common lung cancer is adenocarcinoma, followed by small cell carcinoma and squamous cell carcinoma. Over the last years there has been a steady rise in the incidence of adenocarcinoma in men and a rise of small cell carcinoma in women. If this trend continues the death rates among women for lung cancer may rapidly increase because the survival of small cell carcinoma is poor. These changes in the distribution of lung cancer are important to plan strategies for early detection of lung cancer particularly for small cell carcinoma.
My research on lung cancer involves collaborations from 3 large university centers in Texas to determine the distribution of lung cancer according to histologic type, sex, smoking and patient age for the past 23 years and to find out any changes in the trends of lung cancer type and its relation to patient survival. In addition, I am interested in studying the clinicopathologic process in different disciplines in surgical pathology including non-neoplastic lung disease, intraoperative histo-cytologic correlation and breast cancer.